Family-friendly walk or run pays tribute to cancer survivors
AUSTIN, Texas, April 27, 2017 /3BL Media/ – In celebration of its 20th Anniversary, the LIVESTRONG Foundation – a global leader and pioneer in cancer patient survivorship – announced today the launch of The LIVESTRONG Honor 5k/10k, which will take place on September 17 in downtown Austin. Participants are encouraged to wear commemorative bibs featuring the name of a “Cancer Warrior” in honor of the brave, inspiring survivors of the life-threatening disease.
FOSTER CITY, Calif., May 1, 2017 /3BL Media/ - Gilead Sciences, Inc. today announced that it issued its Year in Review 2016 report, a combination of the company’s Annual Report and Corporate Social Responsibility report. This report provides an in-depth look into Gilead’s commitment to develop and deliver innovative therapies that change lives.
The report focuses on four key areas: giving and access, people, products and environment as well as a financial overview. Highlights include:
CAMBRIDGE, Mass., April 18, 2017 /3BL Media/ -- PatientsLikeMe and Shire plc have announced a new collaboration that will support the development of a patient-centered, real world health learning system that expands understanding of patient health and disease. Philip Vickers, PhD, Head of Research and Development for Shire, said working with PatientsLikeMe will help the company overcome some of the traditional challenges inherent in understanding rare diseases.
Supports Healthy for Life® Commitment with American Heart Association by Establishing Feed Your Potential 365 Clubs in Communities Nationwide & Offering Online Curriculum to 500+ Non-Profit Organizations
PHILADELPHIA, April 12, 2017 /3BL Media/ -- As part of its five-year commitment with the American Heart Association to improve the health of Americans 20 percent by 2020, Aramark (NYSE: ARMK), a global leader in food, facilities management and uniforms, is launching Feed Your Potential 365, a public health and well-being campaign, to promote healthy lifestyles among all consumers, as well as families in underserved communities and Aramark’s customers, clients and employees.
By Chris Boerner, President and Head of U.S. Commercial
Over the past four decades, we have seen an unprecedented increase in cancer care innovation.
While only half of diagnosed cancer patients survived beyond five years in the 1970s, more than two-thirds do today. As a result, there are now a record 14 million cancer survivors in the United States.
It can take longer to diagnose rare diseases than many common diseases. On average, rare disease diagnosis takes 7.6 years in the U.S. and 5.6 years in the UK. Rare diseases such as the primary immunodeficiency (PI) disorders Gaucher disease, Fabry disease, and Hunter syndrome can be devastating, as they are difficult to detect and equally difficult to treat. 60,000 Our U.S. patient assistance programs reached approximately 60,000 patients. We have 37 programs in clinical development, the most robust pipeline in Shire’s history.